Forefront Analytics, LLC Codiak Bio Sciences, Inc. Transaction History

Forefront Analytics, LLC

  • $209 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$0.18 - $0.81 $1,849 - $8,322
10,275 Added 10.28%
110,210 $19,000
Q4 2022

Feb 13, 2023
BUY
$0.32 - $0.9 $13,904 - $39,105
43,450 Added 76.92%
99,935 $39,000
Q3 2022

Nov 14, 2022
BUY
$0.82 - $3.19 $31,303 - $121,778
38,175 Added 208.49%
56,485 $47,000
Q2 2022

Aug 10, 2022
SELL
$2.24 - $6.96 $2,240 - $6,960
-1,000 Reduced 5.18%
18,310 $57,000
Q1 2022

May 09, 2022
BUY
$4.3 - $12.95 $83,033 - $250,064
19,310 New
19,310 $122,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Codiak BioSciences, Inc.

CDAK Quotes by TradingView
  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email